SUVRETTA CAPITAL MANAGEMENT, LLC 13D and 13G filings for ProKidney Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-22 3:32 pm Purchase |
2024-08-28 | 13G | ProKidney Corp. PROK |
SUVRETTA CAPITAL MANAGEMENT, LLC | 13,198,766 10.470% |
8,473,418 (+179.32%) |
Filing |
| 2024-02-13 5:27 pm Sale |
2023-12-31 | 13G | ProKidney Corp. PROK |
SUVRETTA CAPITAL MANAGEMENT, LLC | 4,725,348 7.000% |
-1,554,827 (-24.76%) |
Filing |
| 2023-02-13 4:37 pm Purchase |
2022-12-31 | 13G | ProKidney Corp. PROK |
SUVRETTA CAPITAL MANAGEMENT, LLC | 6,280,175 10.200% |
10,875 (+0.17%) |
Filing |
| 2022-07-21 5:44 pm Purchase |
2022-07-11 | 13G | ProKidney Corp. PROK |
SUVRETTA CAPITAL MANAGEMENT, LLC | 6,269,300 10.200% |
6,269,300 (New Position) |
Filing |